ANI Pharmaceuticals
ANIP
ANIP
201 hedge funds and large institutions have $963M invested in ANI Pharmaceuticals in 2024 Q2 according to their latest regulatory filings, with 32 funds opening new positions, 75 increasing their positions, 62 reducing their positions, and 29 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more ownership
Funds ownership: →
1% more funds holding
Funds holding: 200 → 201 (+1)
1% less capital invested
Capital invested by funds: $975M → $963M (-$12.2M)
Holders
201
Holding in Top 10
1
Calls
$3.16M
Puts
$566K
Top Buyers
| 1 | +$19.1M | |
| 2 | +$15.9M | |
| 3 | +$13.3M | |
| 4 |
Macquarie Group
Sydney, NSW 2000,
Australia
|
+$11.1M |
| 5 |
GACM
Global Alpha Capital Management
Montreal,
Quebec, Canada
|
+$8.67M |
Top Sellers
| 1 | -$22.7M | |
| 2 | -$22.6M | |
| 3 | -$4.29M | |
| 4 |
CSS
Cubist Systematic Strategies
Stamford,
Connecticut
|
-$3.85M |
| 5 |
Jane Street
New York
|
-$2.62M |